[1]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132-134.[doi:10.3969/j.issn.1006-1959.2018.18.042]
　BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(18):132-134.[doi:10.3969/j.issn.1006-1959.2018.18.042]
点击复制

益生元对2型糖尿病患者糖脂代谢的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年18期
页码:
132-134
栏目:
药物与临床
出版日期:
2018-09-15

文章信息/Info

Title:
Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus
文章编号:
1006-1959（2018）18-0132-03
作者:
鲍 哲; 杨升伟; 柯赛赛; 王天荣; 王荣正; 黄锦婷
浙江省温岭市中医院内分泌代谢科，浙江 温岭 317500
Author(s):
BAO Zhe; YANG Sheng-wei; KE Sai-sai; WANG Tian-rong; WANG Rong-zheng; HUANG Jin-ting
Department of Endocrinology and Metabolism,Wenling Hospital of Traditional Chinese Medicine,Wenling 317500,Zhejiang,China
关键词:
益生元; 2型糖尿病; 血糖血脂代谢
Keywords:
Key words：Prebiotics; Type 2 diabetes mellitus; Blood glucose and lipid metabolism
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2018.18.042
文献标志码:
A
摘要:
目的 探讨益生元对2型糖尿病患者血糖血脂代谢的影响，分析益生元在糖尿病进程中的作用。方法 选取2017年1月~2018年3月本院104例2型糖尿病患者，按随机数字表法分为对照组和实验组，每组52例，对照组给予安慰剂，实验组服用益生元，12周后再次检测血液中的血糖血脂生化指标，统计分析服用前后生化指标的变化。结果 实验组服用12周益生元后，患者空腹血糖、餐后2 h血糖、糖化血红蛋白、胆固醇及低密度脂蛋白水平低于治疗前，差异有统计学意义 (P＜0.05)。治疗后实验组糖脂生化指标中空腹血糖、糖化血红蛋白、胆固醇及低密度脂蛋白浓度水平均低于对照组，差异具有统计学意义 (P＜0.05)；治疗后两组餐后2 h血糖、甘油三酯、高密度脂蛋白对比，差异无统计学意义（P＞0.05）。结论 补充益生元有助于降低2型糖尿病患者的空腹血糖、糖化血红蛋白、胆固醇及低密度脂蛋白浓度水平，对2型糖尿病患者的血糖及血脂可能具有积极的作用。
Abstract:
Abstract：Objective To investigate the effect of prebiotics on blood glucose and lipid metabolism in patients with type 2 diabetes mellitus,and to analyze the role of prebiotics in the progression of diabetes.Methods A total of 104 patients with type 2 diabetes mellitus from January 2017 to March 2018 were enrolled.The patients were divided into the control group and the experimental group according to the random number table.52 patients in each group,the control group was given a placebo,and the experimental group was given a prebiotic,after 12 weeks,the biochemical indicators of blood glucose and blood lipids were again detected,and the changes of biochemical indicators before and after taking were statistically analyzed.Results After taking the prebiotics for 12 weeks in the experimental group,the levels of fasting blood glucose,2 h postprandial blood glucose,glycated hemoglobin,cholesterol and low density lipoprotein in the blood of the patients were lower than those before treatment,the difference was statistically significant(P<0.05).After treatment,the concentration of glycosaminoglycan,glycosylated hemoglobin,cholesterol and low density lipoprotein in the experimental group were lower than the control group,the difference was statistically significant(P<0.05). After treatment,the two groups had 2 h postprandial blood glucose.There was no significant difference in the comparison of triglyceride and high density lipoprotein(P>0.05).Conclusion Supplementation of prebiotics can help reduce the levels of fasting blood glucose, glycosylated hemoglobin,cholesterol and low-density lipoprotein in patients with type 2 diabetes mellitus,and may have a positive effect on blood sugar and blood lipids in patients with type 2 diabetes mellitus.

参考文献/References:


[1]禤立平,徐敏,刘瑞欣,等.肠道菌群与2 型糖尿病研究现状及进展[J].中华内分泌代谢杂志,2016,32(12):1041-1044.
[2]Fernandes JDR,Ogurtsova K,Linnenkamp U,et al.IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes[J].Diabetes Research&Clinical Practice,2016(117):48-54.
[3]Han JL,Lin HL.Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective[J].World J Gastroenterol.2014,20(47):17737-17745.
[3]Hu YM,Feng Z,Yin Y,et al.Effects of probiotics supplement in patients with type 2 diabetes mellitus:A meta-analysis of randomized trials[J].Medicina Clínica,2017,148(8):362-370.
[4]Hutkins RW,Krumbeck JA,Bindels LB,et al.Prebiotics:why definitions matter[J].Current Opinion in Biotechnology,2016(37):1-7.
[5]武庆斌.益生元与婴儿肠道健康[J].中华儿科杂志,2017,55(7):484-486.
[6]蒋晨,周刊,侯晓华.益生元效应:回顾与展望[J].临床消化病杂志,2017,29(3):176-179.
[7]Musso G,Gambino R,Cassader M.Obesity,diabetes,and gut microbiota the hygiene hypothesis expanded[J].Diabetes Care,2010,33(10):2277-2284.
[8]Hill C,Guarner F,Reid G,et al.Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J].Nat Rev Gastroenterol Hepatol,2014,11(8):506-514.
[9]Forsythe P,Kunze WA.Voices from within:gut microbes and the CNS[J].Cell Mol Life Sci,2013,70(1):55-69.
[10]郑建仙.功能性低聚糖[M].北京:化学工业出版社,2004:1-6.
[11]韩瑶,吴正钧术,鄢明辉,等.益生菌防治糖尿病的研究进展[J].乳业科学与技术,2016,36(9):20-24.
[12]Zhuang G,Liu XM,Zhang QX,et al.Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics[J].Clinical Lipidology,2012,7(5):501-507.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(18):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(18):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(18):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(18):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(18):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(18):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(18):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(18):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(18):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(18):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]

更新日期/Last Update: 2018-09-15